| | | | | | | |
 | GILEAD SCIENCES, INC. | -1.32% | 2.24% | -15.87% | -11.18% | -4.52% | 76 626 |
| VERTEX PHARMACEUTICALS | 4.80% | 2.72% | 31.16% | 43.53% | 62.78% | 73 868 |
| REGENERON PHARMACEUTICALS, INC. | -0.22% | 5.49% | -2.84% | 0.45% | 104.36% | 65 600 |
| BIONTECH SE | 1.48% | 10.87% | -28.97% | -52.93% | --.--% | 44 499 |
 | WUXI APPTEC CO., LTD. | 0.40% | 2.25% | -19.26% | -34.96% | 155.71% | 41 093 |
 | GENMAB A/S | -2.37% | -1.46% | -2.78% | -10.25% | 108.31% | 22 792 |
 | ARGENX SE | 0.50% | 0.84% | 14.24% | 36.96% | 200.42% | 20 143 |
| BEIGENE, LTD. | 1.77% | 15.70% | -28.22% | -39.50% | 48.17% | 20 122 |
| NEUROCRINE BIOSCIENCES, INC. | 8.45% | 10.53% | 22.16% | 16.15% | 9.57% | 9 944 |
| SAREPTA THERAPEUTICS, INC. | 4.50% | 14.06% | 17.73% | 32.86% | -26.12% | 9 284 |
| LEGEND BIOTECH CORPORATION | -0.34% | 5.52% | 6.95% | 17.52% | --.--% | 8 119 |
| EXELIXIS, INC. | 0.37% | 2.87% | 17.72% | 24.75% | 6.32% | 6 902 |
| HALOZYME THERAPEUTICS, INC. | -0.57% | -7.71% | 12.24% | 11.43% | 163.15% | 6 218 |
 | PHARMAESSENTIA CORPORATION | 5.99% | 9.36% | 111.26% | 534.87% | 387.40% | 5 860 |
| INTRA-CELLULAR THERAPIES, INC. | 2.08% | 10.85% | 14.62% | 79.13% | 594.33% | 5 659 |
| | | | | | | |
| | Media | 1.70% | 5.61% | 10.01% | 43.26% | 139.22% | |
| | Media ponderata per Capi. | 1.16% | 4.74% | -0.36% | 6.59% | 86.66% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
